GS MedTech Funding Tracker – NVision, BlueWind, and more

GS Funding Tracker
A clear commercialization push defines this week’s MedTech activity, as companies across neuromodulation, ultrasound therapy, and surgical devices advance through late-stage clinical programs and market entry. Complete updates follow below. NVision raises $55M to expand...

GS MedTech Funding Tracker – NVision, BlueWind, and more

GS Funding Tracker
A clear commercialization push defines this week’s MedTech activity, as companies across neuromodulation, ultrasound therapy, and surgical devices advance through late-stage clinical programs and...

BlueWind Medical raises $47.8M to support Revi commercialization

Funding
BlueWind Medical announced that it closed a financing worth $47.8 million in a combination of equity and debt. Salt Lake City-based BlueWind plans to use...

Epineuron receives FDA 510(k) clearance for Evala Nerve Stimulator

Regulatory Approvals
Epineuron, a medical device company pioneering bioelectronic medicine, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Evala®...

Rivermark secures $20M in Series D for late-stage prostate device trial

Funding
Wisconsin-based medtech Rivermark Medical has secured $20m in a Series D financing round – supporting the company’s late-stage clinical activities being used for approval...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Reprieve Cardiovascular pilot study backs heart failure system

Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy. Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...

MMI completes first robotic-assisted procedure in Alzheimer’s patient

Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study. REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...

CVRx enrolls first patient in study of Barostim therapy for heart failure

CVRx announced that it enrolled the first patient in its landmark BENEFIT-HF study of its Barostim therapy. Barostim delivers electrical pulses to baroreceptors in the...

Sensome reports positive findings for clot-sensing guidewire

Sensome announced the publication of first-in-human results from the CLOT OUT study evaluating its Clotild smart guidewire system. Findings published in the Journal of Neurointerventional...

Innovation

Regulatory Approvals

GS MedTech Funding Tracker – NVision, BlueWind, and more

A clear commercialization push defines this week’s MedTech activity, as companies across neuromodulation, ultrasound therapy, and surgical devices advance through late-stage clinical programs and...

BlueWind Medical raises $47.8M to support Revi commercialization

BlueWind Medical announced that it closed a financing worth $47.8 million in a combination of equity and debt. Salt Lake City-based BlueWind plans to use...

Epineuron receives FDA 510(k) clearance for Evala Nerve Stimulator

Epineuron, a medical device company pioneering bioelectronic medicine, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Evala®...

Rivermark secures $20M in Series D for late-stage prostate device trial

Wisconsin-based medtech Rivermark Medical has secured $20m in a Series D financing round – supporting the company’s late-stage clinical activities being used for approval...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1132Regulatory Approvals1016Innovation655Clinical Trials521Mergers & Acquisitions506GS Funding Tracker49